8-K/A: TruBridge Revises 2024 Results, Cites Revenue Recognition Error, Reaffirms 2025 Outlook

TruBridge, Inc. amended its previously reported Q4 and full-year 2024 results due to an error in revenue recognition, increasing 2024 revenue by $3.5 million and decreasing 2023 revenue by the same amount, while reiterating its 2025 financial outlook.

Summary

• TruBridge, Inc. has revised its previously issued financial results for the fourth quarter and full year 2024 due to an error related to the reversal of revenue from customers that was improperly recognized in the prior year.
• The revision increased revenue for the year ended December 31, 2024, by $3.5 million and decreased revenue for the year ended December 31, 2023, by the same amount.
• The company's total revenue for 2024 was $342.6 million, with $88.2 million in the fourth quarter.
• The net loss for 2024 was $20.4 million, and $5.0 million for the fourth quarter.
• Adjusted EBITDA was $56.6 million for 2024 and $18.1 million for the fourth quarter.
• TruBridge is reporting two segments: Financial Health and Patient Care.
• For the first quarter of 2025, TruBridge expects total revenue between $85 million and $88 million and adjusted EBITDA between $14 million and $16 million.
• For the full year 2025, TruBridge expects total revenue between $345 million and $360 million and adjusted EBITDA between $59 million and $66 million.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While there was a need to revise financial statements due to an error, the company still reported results ahead of expectations, reduced its leverage ratio, and provided a positive outlook for 2025.

Positives

• The company's revenue and adjusted EBITDA were ahead of expectations for the year.
• TruBridge successfully transitioned the first wave of clients to its global workforce.
• The company meaningfully reduced its leverage ratio.
• TruBridge achieved solid organic growth in Financial Health.
• The company improved cash flows with significant debt repayment.
• Recurring revenue represented 95.5% of total revenue for 2024.

Negatives

• The company had to revise its previously issued financial results due to a revenue recognition error.
• TruBridge reported a net loss of $20.4 million for 2024 and $5.0 million for the fourth quarter.

Risks

• The company faces risks related to market saturation, hospital consolidations, and unfavorable economic conditions.
• Legislative and regulatory uncertainty in the healthcare industry poses a risk.
• Competition from companies with greater financial, technical, and marketing resources is a concern.
• The company's substantial indebtedness and restrictive terms of its credit agreement could impact operations.
• The company is exposed to risks related to the use of offshore third-party resources.
• The company is exposed to competitive and litigation risk related to the use of artificial intelligence.
• The company is vulnerable to significant damage from natural disasters.

Future Outlook

TruBridge expects total revenue between $345 million and $360 million and adjusted EBITDA between $59 million and $66 million for the full year 2025.

Management Comments

• Chris Fowler, chief executive officer of TruBridge, Inc., stated, 'I'm proud of the progress we made over the course of 2024 and pleased to be reporting revenue and adjusted EBITDA ahead of our expectations for the year.'
• Fowler also stated, 'We've successfully strengthened our financial operations and executed key strategic initiatives, including the successful transition of the first wave of clients to our global workforce, while maintaining our commitment to customer satisfaction and meaningfully reducing our leverage ratio.'
• Looking ahead to 2025, we are focused on enhancing customer satisfaction and retention, optimizing our operations, and expanding our sales pipeline.

Industry Context

TruBridge operates in the healthcare solutions industry, providing technology-first solutions to healthcare organizations. The company's focus on revenue cycle management (RCM) and electronic health record (EHR) product offerings aligns with the industry's need for efficient patient care and financial health.

Comparison to Industry Standards

• Without specific competitor data, it's difficult to provide a precise comparison.
• However, companies like Cerner (now Oracle Health), Allscripts, and athenahealth are key players in the EHR and RCM space.
• TruBridge's adjusted EBITDA margin of 16.5% for 2024 can be benchmarked against these competitors to assess its profitability.
• The company's recurring revenue of 95.5% indicates a stable revenue base, which is a positive sign compared to industry averages.

Management Changes

Stakeholder Impact

• Shareholders may experience short-term volatility due to the revision of financial results.
• Employees may benefit from the company's focus on operational excellence and growth.
• Customers can expect continued investment in customer satisfaction and retention.
• Suppliers may see increased business opportunities as the company expands its operations.

Next Steps

• TruBridge will continue to focus on enhancing customer satisfaction and retention.
• The company will optimize its operations and expand its sales pipeline.
• TruBridge will continue to invest in its offshore capabilities.
• The company will release Q1 2025 results.

Key Dates

Keywords

TruBridge, financial results, revenue, adjusted EBITDA, healthcare solutions, revenue cycle management, financial health, patient care, bookings, outlook, financial statements, non-GAAP, EHR